13422gmol

13422gmol is a chemical compound with the molecular formula C10H14N2O2. It is a derivative of the benzodiazepine class of drugs, specifically a triazolobenzodiazepine. This compound is known for its anxiolytic and sedative properties, making it a subject of interest in the field of pharmacology and psychiatry.

The synthesis of 13422gmol involves the reaction of 7-chloro-5-phenyl-1,3-benzodiazepine-2-one with 1,2,4-triazole. This process typically requires the use of a suitable solvent and a catalyst to facilitate the reaction. The resulting compound is then purified through various methods, such as recrystallization or chromatography, to obtain a pure sample.

13422gmol has been studied for its potential therapeutic applications, particularly in the treatment of anxiety disorders. Animal studies have shown that the compound can reduce anxiety-like behaviors in models of stress and anxiety. However, further research is needed to fully understand its pharmacokinetics, pharmacodynamics, and safety profile in humans.

The chemical structure of 13422gmol includes a benzodiazepine ring fused with a triazole ring, which is responsible for its unique pharmacological properties. The presence of the triazole ring is believed to contribute to the compound's anxiolytic effects by modulating the activity of certain neurotransmitters, such as gamma-aminobutyric acid (GABA).

In summary, 13422gmol is a triazolobenzodiazepine derivative with anxiolytic and sedative properties. Its synthesis involves the reaction of 7-chloro-5-phenyl-1,3-benzodiazepine-2-one with 1,2,4-triazole, followed by purification. Further research is required to fully explore its potential as a therapeutic agent for anxiety disorders.